What is CBD Global Sciences Inc. (CBDNF)?

CBD Global Sciences Inc. (CBDNF) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of CBDNF?

The current price of CBDNF is $0.04. Prices are updated in real time on Stocks360.

What is CBDNF's price-to-earnings (PE) ratio?

CBDNF's trailing twelve-month PE ratio is -0.28, based on current price and earnings per share data available on Stocks360.

What is CBDNF's market capitalization?

CBDNF's market capitalization is $2,072,232.00, placing it in the small-cap tier.

CBD Global Sciences Inc. (CBDNF)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$0.04

Market Cap

$2.07M

PE (TTM)

-0.28

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.43

Day Range

$0.04 – $0.04

52-wk Range

$0.02 – $0.12

Avg Volume

N/A

Volume

770.00

CBD Global Sciences Inc. (CBDNF) is a publicly traded company in the Healthcare sector. Latest price: $0.04. Market cap $2.07M. Trailing PE -0.28. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About CBD Global Sciences Inc.

CBD Global Sciences Inc. operates within the cannabidiol (CBD) sector, handling the cultivation, processing, and manufacturing of CBD products. Its offerings include biomass, various CBD oils, and other CBD-based items, which are marketed under the Aethics, CannaOil, and Strasburg Pharms brands. Founded in 2018, the company's main offices are located in Lakewood, Colorado.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.28×
P/S (TTM)	12.41×
P/B	-0.88×
P/FCF (TTM)	-1.82×
EV / EBITDA	-1.08×
EV / Sales	26.14×
Earnings Yield	-351.31%
Free Cash Flow Yield	-55.09%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$4.36M
Revenue (TTM)	$166.95K
Net Income (TTM)	-$7.28M
Free Cash Flow (TTM)	-$540.98K
Net Debt	$2.29M
Working Capital	-$1.74M
Gross Margin	24.56%
Operating Margin	-1641.21%
Net Margin	-3146.33%
Return on Equity	105.36%
Return on Invested Capital	-391.67%